Test Price
7,000 AED✅ Home Collection Available
Non‑Invasive Prenatal Paternity DNA Test in Dubai
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity with Next‑Generation Sequencing (NGS) of over 2,900 SNP markers, processed in our ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited laboratory.
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection, available daily from 8 AM to 11 PM, performed by DHA‑licensed phlebotomists.
Clinical Guidance: Post‑test telephonic consultation with a senior Consultant Medical Geneticist to interpret results and discuss familial implications.
Insurance & Support: Direct billing verification and pre‑authorisation support via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Non‑Invasive Prenatal Paternity (NIPP) test establishes biological fatherhood definitively as early as 8 weeks of gestation. The test analyzes cell‑free fetal DNA (cffDNA) circulating in the maternal bloodstream using advanced NGS bioinformatics. There is zero risk to the pregnancy or fetus as only a standard maternal blood draw and a non‑invasive buccal swab from the alleged father are required. All specimens are processed under strict forensic chain‑of‑custody protocols meeting DHA evidentiary standards.
| Feature | Our Test (DNA Labs UAE) | Invasive Amniocentesis‑based Test |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – cell‑free fetal DNA | PCR/STR analysis on amniotic fluid cells |
| Risk to Mother/Fetus | Zero – non‑invasive blood and buccal collection | Miscarriage risk (1/300–1/500) |
| Turnaround Time | 10–12 working days | 14–21 days |
| Legal Admissibility | Yes – accredited forensic report for courts | Yes |
| Price (AED) | 7,000 | 18,000–25,000 |
*Pricing includes priority logistics, physician consultation, and a legally admissible forensic report.
Physician Insight & Safety Protocols
“A prenatal paternity result carried to 99.9% accuracy provides a definitive biological fact, yet it must be integrated responsibly into a family’s medical and psychosocial narrative. I strongly advise all parents to engage in pre‑ and post‑test genetic counselling. Our role is to provide irrefutable scientific evidence through validated laboratory genetics; your physician and genetic counsellor will help frame this information within your complete health and family history. The ethical weight of this knowledge demands careful, informed interpretation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Pre‑Test Advisory: Medication & Health Stability
⚠ Do Not Alter Prescribed Medication
Do not discontinue or adjust any prescribed medication without consulting your treating doctor. Medications for hypertension, diabetes, thyroid disorders, or anticoagulants do not interfere with the DNA analysis, but altering them without supervision may directly compromise maternal or fetal health. Maintain all existing treatment schedules during the testing window.
Exclusion Criteria & When to Seek Urgent Care
- This test cannot be performed if the maternal patient has ever received a bone marrow or organ transplant.
- Not suitable for pregnancies below 8 weeks’ gestation; early testing may yield an inadequate fetal DNA fraction.
- A recent blood transfusion (within 4 weeks) may interfere with cell‑free DNA analysis – please inform our clinical team before scheduling.
- Multiple‑gestation pregnancies require dedicated pre‑test counselling; contact our genetics department before booking.
🚨 Red Flags: If you experience heavy vaginal bleeding, severe abdominal pain, or signs of miscarriage, do not wait for test results – proceed immediately to the nearest Emergency Department.
Patient FAQ & Clinical Guidance
1. What is the accuracy of the Non‑Invasive Prenatal Paternity test?
Answer: The test delivers a diagnostic accuracy exceeding 99.9%. By sequencing over 2,900 SNP markers from cell‑free fetal DNA against the alleged father’s genomic profile, our validated bioinformatics pipeline ensures a conclusive result when a sufficient fetal DNA fraction is present. This methodology meets DHA forensic standards for legal admissibility in UAE courts.
2. How long does it take to get the results after sample collection?
Answer: Your legally binding report is available within 10 to 12 working days from the date of sample receipt at our DHA‑licensed facility. The process involves DNA extraction, library preparation, NGS sequencing, bioinformatics analysis, and a dual‑review by two independent scientists. An expedited service (7 working days) is available for urgent legal timelines upon request.
3. Can the test be performed at home without visiting the laboratory?
Answer: Yes. Our VIP Mobile Phlebotomy service dispatches a certified professional to your residence between 8 AM and 11 PM. A maternal blood sample and a buccal swab from the alleged father are collected using ISO‑certified cold‑chain protocols. The samples are transported under strictly monitored temperature conditions directly to our laboratory, preserving the chain of custody required for legal admission. No visit to our facility is necessary.
4. Is the report legally admissible in UAE courts and for family law matters?
Answer: Yes, the final report is fully legally admissible. The entire workflow, from sample collection to report issuance, adheres to the DHA’s forensic chain‑of‑custody standards and the evidentiary requirements of UAE family law. The document is signed by our licensed Consultant Medical Geneticist and can be used for immigration applications, family law proceedings, inheritance claims, and personal identification matters within the UAE.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with the UAE’s federal data protection and health information governance frameworks. Patient confidentiality and genetic data integrity are protected under:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, processing, and storage of personal and genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – regulating digital health records and telemedicine consultations.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – ensuring clinical safety, informed patient consent, and professional accountability.
All genetic results are encrypted and accessible only to the ordering physician and the patient. Data sharing with third parties requires explicit written consent in accordance with PDPL standards.
Clinical & Logistical Metadata
| Test Name | Non‑Invasive Prenatal Paternity (NIPP) Test |
| Price (AED) | 7,000 AED |
| Turnaround Time | 10–12 Working Days (Express 7 Days Available) |
| Sample Type / Matrix | Maternal Peripheral Blood (Plasma) + Alleged Father Buccal Swab or Blood |
| Methodology Used | Next‑Generation Sequencing (NGS) of Single Nucleotide Polymorphisms (SNPs) |
| ICD-10-CM Code | Z36.89, Z31.5 |
| LOINC Code | 82719-9 |
| DHA Facility License & Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians